Literature DB >> 32170607

White matter changes from mild cognitive impairment to Alzheimer's disease: a meta-analysis.

Linzi Qin1,2, Zhiwei Guo1, Morgan A McClure1, Qiwen Mu3,4,5.   

Abstract

Previous diffusion tensor imaging (DTI) studies have reported that both mild cognitive impairment (MCI) and Alzheimer's disease (AD) revealed microstructural changes [fractional anisotropy (FA)]. However, these results were not conclusive. The purpose of this meta-analysis was to identify the consistent FA alterations and the differences between MCI and AD. Case-control studies investigating MCI and AD using FA were searched in the online databases. The quantitative FA value of cognition-related brain regions was extracted and the standardized mean difference (SMD) with 95% confidence interval (CI) was calculated using fixed or random effect models. Twenty six studies with a total of 1,021 patients were included in this meta-analysis. Significantly decreased FA in patients with AD were identified in the left frontal lobe, corpus callosum (CC), fornix, hippocampus (HP), cingulate gyrus (CG), cingulate bundle (CB), uncinate fasciculus (UF), superior longitudinal fasciculus(SLF), the inferior fronto-occipital fascicles (IFOF), and the inferior longitudinal fasciculus(ILF) relative to MCI in this meta-analysis. This study provides objective and quantitative evidence that AD is associated with FA alteration within left frontal lobe, CC, FX, HP, CG, CB, and UF may suggest the key regions of the process from MCI to AD.
© 2020. Belgian Neurological Society.

Entities:  

Keywords:  Alzheimer’s disease; Diffusion tensor imaging; Fractional anisotropy; Meta-analysis; Mild cognitive impairment

Mesh:

Year:  2020        PMID: 32170607     DOI: 10.1007/s13760-020-01322-5

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  36 in total

1.  Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.

Authors:  Michelle M Mielke; Ozioma C Okonkwo; Kenichi Oishi; Susumu Mori; Sarah Tighe; Michael I Miller; Can Ceritoglu; Timothy Brown; Marilyn Albert; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012       Impact factor: 21.566

Review 2.  Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review.

Authors:  Yaniv Assaf; Ofer Pasternak
Journal:  J Mol Neurosci       Date:  2008       Impact factor: 3.444

3.  Alzheimer's disease: a global challenge for the 21st century.

Authors:  Jean François Dartigues
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

4.  Menopausal hormone therapy and mild cognitive impairment: a randomized, placebo-controlled trial.

Authors:  Byung-Koo Yoon; Juhee Chin; Jong-Won Kim; Myung-Hee Shin; Soohyun Ahn; Dong-Yun Lee; Sang Won Seo; Duk L Na
Journal:  Menopause       Date:  2018-08       Impact factor: 2.953

5.  Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.

Authors:  Rachelle S Doody; Ronald G Thomas; Martin Farlow; Takeshi Iwatsubo; Bruno Vellas; Steven Joffe; Karl Kieburtz; Rema Raman; Xiaoying Sun; Paul S Aisen; Eric Siemers; Hong Liu-Seifert; Richard Mohs
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

6.  Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.

Authors:  Matthew Davis; Thomas O Connell; Scott Johnson; Stephanie Cline; Elizabeth Merikle; Ferenc Martenyi; Kit Simpson
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

Review 7.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

8.  Do Alzheimer-specific microstructural changes in mild cognitive impairment predict conversion?

Authors:  Thomas van Bruggen; Bram Stieltjes; Philipp A Thomann; Peter Parzer; Hans-Peter Meinzer; Klaus H Fritzsche
Journal:  Psychiatry Res       Date:  2012-09-01       Impact factor: 3.222

9.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Authors:  Stephen Salloway; Reisa Sperling; Nick C Fox; Kaj Blennow; William Klunk; Murray Raskind; Marwan Sabbagh; Lawrence S Honig; Anton P Porsteinsson; Steven Ferris; Marcel Reichert; Nzeera Ketter; Bijan Nejadnik; Volkmar Guenzler; Maja Miloslavsky; Daniel Wang; Yuan Lu; Julia Lull; Iulia Cristina Tudor; Enchi Liu; Michael Grundman; Eric Yuen; Ronald Black; H Robert Brashear
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

10.  Enhancing memory performance with rTMS in healthy subjects and individuals with Mild Cognitive Impairment: the role of the right dorsolateral prefrontal cortex.

Authors:  Patrizia Turriziani; Daniela Smirni; Giuseppe Zappalà; Giuseppa R Mangano; Massimiliano Oliveri; Lisa Cipolotti
Journal:  Front Hum Neurosci       Date:  2012-04-10       Impact factor: 3.169

View more
  1 in total

1.  Plasma β-Amyloid Levels Associated With Structural Integrity Based on Diffusion Tensor Imaging in Subjective Cognitive Decline: The SILCODE Study.

Authors:  Xiaoni Wang; Mingyan Zhao; Li Lin; Ying Han
Journal:  Front Aging Neurosci       Date:  2021-01-12       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.